Quark spin coupling in baryons - revisited

A direct connection can be made between mixing angles in negative parity baryons and the spin coupling of constituent quarks. The mixing angles do not depend on spectral data. These angles are recalculated for gluon exchange and pion exchange between quarks. For pion exchange the results of Glozman and Riska are corrected. The experimental data on mixing are very similar to those derived from gluon exchange but substantially different from the values obtained for pion exchange.Comment: 10 pages, RevTex; a sign error is corrected, spin-orbit results are include

Chiral sedimentation of extended objects in viscous media

We study theoretically the chirality of a generic rigid object's sedimentation in a fluid under gravity in the low Reynolds number regime. We represent the object as a collection of small Stokes spheres or stokeslets, and the gravitational force as a constant point force applied at an arbitrary point of the object. For a generic configuration of stokeslets and forcing point, the motion takes a simple form in the nearly free draining limit where the stokeslet radius is arbitrarily small. In this case, the internal hydrodynamic interactions between stokeslets are weak, and the object follows a helical path while rotating at a constant angular velocity $\omega$ about a fixed axis. This $\omega$ is independent of initial orientation, and thus constitutes a chiral response for the object. Even though there can be no such chiral response in the absence of hydrodynamic interactions between the stokeslets, the angular velocity obtains a fixed, nonzero limit as the stokeslet radius approaches zero. We characterize empirically how $\omega$ depends on the placement of the stokeslets, concentrating on three-stokeslet objects with the external force applied far from the stokeslets. Objects with the largest $\omega$ are aligned along the forcing direction. In this case, the limiting $\omega$ varies as the inverse square of the minimum distance between stokeslets. We illustrate the prevalence of this robust chiral motion with experiments on small macroscopic objects of arbitrary shape.Comment: 35 pages, 10 figures; Section VII.A redone and other edits made for clarity. Accepted by Phys. Rev.

Musings on genome medicine: abuse of genetic tests

The wide general publication of a putative genetic test for athletic supremacy is clearly an abuse of genetics and reveals an undercurrent of hucksterism in biomedical science

Musings on genome medicine: enzyme-replacement therapy of the lysosomal storage diseases

The lysosomal storage diseases, such as Gaucher's disease, mucopolysaccharidosis I, II and IV, Fabry's disease, and Pompe's disease, are rare inherited disorders whose symptoms result from enzyme deficiency causing lysosomal accumulation. Until effective gene-replacement therapy is developed, expensive, and at best incomplete, enzyme-replacement therapy is the only hope for sufferers of rare lysosomal storage diseases. Preventive strategies involving carrier detection should be a priority toward the successful management of these conditions

Musings on genome medicine: cholesterol and coronary artery disease

Cholesterol levels and not inflammatory markers are the major variables that pose a risk of coronary artery disease. Diabetes greatly increases the risk at any cholesterol level. Coronary artery disease and cancer are linked by a common protein - an apoptotic protein that also functions as a regulator of insulin secretion

Musings on genome medicine: Crohn's disease

The inflammatory bowel diseases, Crohn's disease and ulcerative colitis, pose a fascinating challenge to specialists in gastroenterology, infectious diseases, immunology and genetics and an often crushing burden to patients and their families

Musings on genome medicine: cancer genetics and the promise of effective treatment

Cancer is the most common acquired genetic disease. Great progress has been made in documenting the genetic abnormalities that cause the disease, and in the future each tumor will be subjected to genetic analysis and the appropriate combination of drugs selected. Although there are serious technological and cost hurdles to surmount and resistance and continued mutation will be a constant problem, the way is clear to rational therapy

Musings on genome medicine: Hepatitis C

Hepatitis C is a viral disease transmitted principally by blood, which affects millions of people worldwide. A significant proportion of those affected develop severe liver disease as a result. Only a fraction of patients are responsive to interferon treatment, highlighting the need for further research into genetic factors involved in response to therapy in order to optimize treatment. The only current approach for end-stage disease is liver transplant, which ironically does not cure the condition, and thus poses a clinical dilemma in the face of liver-donor shortage

Musings on genome medicine: gene therapy

Though the field has moved with glacial speed, gene therapies have been carried out successfully in patients with bone marrow disorders including immune deficiencies. The field may be poised to move forward more rapidly, but many barriers have yet to be surmounted